Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
N Engl J Med · 2025-Feb-13 · PMID 39282913
Overall Survival
Figure 2:. Progression-free Survival According to Blinded Independent Central Review and Overall Survival of Patients Enrolled in the Pancreatic NET Cohort Panel A demonstrates the results of progression-free survival (PFS), as assessed retrospectively per RECIST 1.1 criteria by blinded independent central review (BICR), for patients enrolled in the pNET cohort. For the comparison between treatment groups, two-sided stratified log-rank P-value <0.001. Panel B demonstrates the results of overall survival of patients enrolled in the pNET cohort. Panel C demonstrates the results of PFS according to stratification factors and selected clinical subgroups of patients enrolled in the pNET cohort. For the Histologic Differentiation subgroup analysis, “Moderately differentiated” and “Not specified” subgroups are not displayed in the figure due to having zero PFS events in at least one treatment arm.
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 2 | 1 | 0.0081 | 1.0000 | 0.5203 | 100.0000 | 188 | 13 |
| 2 | 2 | 0.2707 | 0.7309 | 17.4662 | 73.0949 | 416 | 186 |
| 2 | 3 | 0.2719 | 0.7294 | 17.5405 | 72.9393 | 417 | 187 |
| 2 | 4 | 0.2730 | 0.7294 | 17.6149 | 72.9393 | 418 | 187 |
| 2 | 5 | 0.2742 | 0.7294 | 17.6892 | 72.9393 | 419 | 187 |
| 2 | 6 | 0.2753 | 0.7294 | 17.7635 | 72.9393 | 420 | 187 |
| 2 | 7 | 0.2765 | 0.7278 | 17.8378 | 72.7838 | 421 | 188 |
| 2 | 8 | 0.2776 | 0.7278 | 17.9122 | 72.7838 | 422 | 188 |
| 2 | 9 | 0.2788 | 0.7278 | 17.9865 | 72.7838 | 423 | 188 |
| 2 | 10 | 0.2800 | 0.7278 | 18.0608 | 72.7838 | 424 | 188 |
| 2 | 11 | 0.2811 | 0.7278 | 18.1351 | 72.7838 | 425 | 188 |
| 2 | 12 | 0.2823 | 0.7278 | 18.2095 | 72.7838 | 426 | 188 |
| 2 | 13 | 0.2834 | 0.7309 | 18.2838 | 73.0949 | 427 | 186 |
| 2 | 14 | 0.2846 | 0.7309 | 18.3581 | 73.0949 | 428 | 186 |
| 2 | 15 | 0.2857 | 0.7309 | 18.4324 | 73.0949 | 429 | 186 |
| 2 | 16 | 0.2869 | 0.7294 | 18.5068 | 72.9393 | 430 | 187 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 1 | 2026-07-23T18:10:15+00:00 |